Evidence map›Paper›PMID 17593318›Full record

ReviewClinical research in cardiology : official journal of the German Cardiac Society2007

Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.

Matthias Weck

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical research in cardiology : official journal of the German Cardiac Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Screening for undiagnosed diabetes in patients with acute myocardial infarction.Clinical research in cardiology : official journal of the German Cardiac Society · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Matthias WeckClinic Bavaria Kreischa, Department of Diabetes, Metabolism and Endocrinology, An der Wolfsschlucht 1-2, 01731 Kreischa, Germany. mweck@t-online.de
Diabetes Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antihypertensive treatment in diabetes mellitus, especially in diabetics known to have cardiac autonomic neuropathy, may have to consider the status of the autonomic nervous system. In diabetic subjects with cardiac autonomic neuropathy, vagal activity during the night is often reduced. The reduction results in relative or absolute sympathetic activation, which could increase cardiovascular risk. Pathophysiological and clinical data suggests that antihypertensive treatment should reduce rather than induce sympathetic activity in this setting. Beta blocking agents, ACE inhibitors, calcium antagonists of verapamil or diltiazem type and selective imidazoline receptor agonists reduce sympathetic activity and, therefore, may have a beneficial effect in diabetic patients with disturbed sympathovagal balance.

Indexed as

Adrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersCalcium Channel BlockersDiabetes ComplicationsHumansHypertensionImidazoline ReceptorsKidneySympathetic Nervous SystemVagus NerveAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersCalcium Channel BlockersImidazoline Receptors

Identifiers

PMID17593318
OpenAlexW1496762768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.